The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects

Cancers, Journal Year: 2024, Volume and Issue: 16(16), P. 2909 - 2909

Published: Aug. 21, 2024

As the legalization of medical cannabis expands across several countries, interest in its potential advantages among cancer patients and caregivers is burgeoning. However, seeking to integrate into their treatment often encounter frustration when oncologists lack adequate information offer guidance. This knowledge gap exacerbated by scarcity published literature on benefits cannabis, leaving reliant evidence-based data disheartened. comprehensive narrative article, tailored for both clinicians patients, endeavors bridge these informational voids. It synthesizes history, pharmacology, physiology focuses addressing various symptoms prevalent care, including insomnia, nausea vomiting, appetite issues, pain management, anti-cancer effects. Furthermore, delving mechanisms action exploring relevance treatment, this article aims shed light effects oncology.

Language: Английский

---

Phytochemical characterization and cytotoxic potential of extracts from roots and inflorescences of Cannabis sativa L. cv. Eletta Campana

Sustainable Chemistry and Pharmacy, Journal Year: 2023, Volume and Issue: 36, P. 101269 - 101269

Published: Sept. 28, 2023

Language: Английский

---

Discussions on Medical Cannabis: Addressing Missed Opportunities in Cancer Education

Journal of Cancer Education, Journal Year: 2024, Volume and Issue: 39(3), P. 217 - 219

Published: March 11, 2024

Language: Английский

---

Patient out-of-pocket costs for cannabis use during cancer treatment

JNCI Monographs, Journal Year: 2024, Volume and Issue: 2024(66), P. 305 - 312

Published: Aug. 1, 2024

Abstract Background We assessed patient costs associated with cannabis use during cancer treatment. Methods Adults treated for at a large, comprehensive center completed an anonymous survey regarding their thoughts and experiences cancer. Bivariate weighted multivariable logistic regression clinical sociodemographic factors patient-reported out-of-pocket products. Results Overall, 248 users provided data on cost were analyzed. Median monthly was $80 (interquartile range = $25-$150). On analysis, male gender (odds ratio 2.5, 95% confidence interval 1.2 to 5.5, P .026) being 45 years of age or older 7.5, 1.9 30.0, .0042) spending $100 month more cannabis. Of the 166 patients who stopped using early used less than preferred, 28% attributed it 26% lack insurance coverage. Conclusion Cannabis treatment may contribute significant costs, men younger likely pay higher costs.

Language: Английский

---

Cancer Pain Management in Patients with Opioid Use Disorder

Current Addiction Reports, Journal Year: 2024, Volume and Issue: 11(3), P. 475 - 491

Published: May 3, 2024

Language: Английский

---